Corcept Therapeutics Incorporated
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
692.67 |
870.20 |
1,240.55 |
1,742.85 |
2,246.60 |
2,656.46 |
| Przychód Δ r/r |
0.00% |
25.63% |
42.56% |
40.49% |
28.90% |
18.24% |
| Przychód (min) |
685.35 |
848.52 |
1,057.47 |
1,742.85 |
2,082.47 |
2,462.38 |
| Przychód (max) |
704.26 |
895.64 |
1,440.11 |
1,742.86 |
2,424.81 |
2,867.19 |
| EBITDA (średnia) |
197.98 |
248.72 |
354.57 |
498.14 |
642.11 |
759.26 |
| EBIT (średnia) |
195.21 |
245.24 |
349.61 |
491.17 |
633.13 |
748.63 |
| EBIT % |
28.18% |
28.18% |
28.18% |
28.18% |
28.18% |
28.18% |
| Zysk netto (średni) |
132.01 |
121.99 |
278.28 |
705.38 |
966.09 |
1,225.58 |
| Zysk netto % |
19.06% |
14.02% |
22.43% |
40.47% |
43.00% |
46.14% |
| EPS (średnia) |
1.41 |
1.07 |
2.18 |
5.44 |
8.51 |
10.80 |
| Liczba analityków (Przychody) |
3 |
4 |
4 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
4 |
4 |
3 |
1 |
1 |
| symbol |
CORT |
CORT |
CORT |
CORT |
CORT |
CORT |